MedTrace Logo

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

NCT00234988 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2008-07-15

No results posted yet for this study

Summary

The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.

Conditions

Interventions

DRUG

sibutramine hydochloride monohydrate

10 mg QD with the option to increase dose to 15 mg QD up until Week 4

Sponsors & Collaborators

Principal Investigators

  • Global Medical Information 1-800-633-9110 · Abbott

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234988 on ClinicalTrials.gov